Search Results - "de Francisco, Angel L.M"

Secondary hyperparathyroidism: Review of the disease and its treatment by de Francisco, Angel L.M.

“…Most patients with chronic kidney disease (CKD) stage 5 develop secondary hyperparathyroidism (SHPT). SHPT is an adaptive response to CKD and its associated…”
Get full text

Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS) by Macdougall, Iain C, Casadevall, Nicole, Locatelli, Francesco, Combe, Christian, London, Gerard M, Di Paolo, Salvatore, Kribben, Andreas, Fliser, Danilo, Messner, Hans, McNeil, John, Stevens, Paul, Santoro, Antonio, De Francisco, Angel L M, Percheson, Paul, Potamianou, Anna, Foucher, Arnaud, Fife, Daniel, Mérit, Véronique, Vercammen, Els

“…Subcutaneous administration of Eprex(®) (epoetin alfa) in patients with chronic kidney disease (CKD) was contraindicated in the European Union between 2002 and…”
Get full text

A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study by Covic, Adrian, Passlick-Deetjen, Jutta, Kroczak, Miroslaw, Büschges-Seraphin, Beatrix, Ghenu, Adrian, Ponce, Pedro, Marzell, Barbara, de Francisco, Angel L M

“…Different phosphate binders exert differing effects on bone mineral metabolism and levels of regulating hormones. The objective of this post hoc evaluation of…”
Get full text

Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis by Block, Geoffrey A, Martin, Kevin J, de Francisco, Angel L.M, Turner, Stewart A, Avram, Morrell M, Suranyi, Michael G, Hercz, Gavril, Cunningham, John, Abu-Alfa, Ali K, Messa, Piergiorgio, Coyne, Daniel W, Locatelli, Francesco, Cohen, Raphael M, Evenepoel, Pieter, Moe, Sharon M, Fournier, Albert, Braun, Johann, McCary, Laura C, Zani, Valter J, Olson, Kurt A, Drüeke, Tilman B, Goodman, William G

“…Hypercalcemia and hyperphosphatemia often complicate secondary hyperparathyroidism therapy in patients who are receiving dialysis. Unlike vitamin D and…”
Get full text

Onco-Nephrology: Cancer, chemotherapy and kidney by de Francisco, Angel L.M., Macía, Manuel, Alonso, Fabiola, García, Patricia, Gutierrez, Eduardo, Quintana, Luis Fernando, Quiroga, Borja, Torregrosa, Isidro

“…Chronic kidney disease (CKD), cancer and hematological diseases share areas of reciprocal influence. Cancer can affect the kidney either as glomerular lesions…”
Get full text

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants With CKD Not Receiving Dialysis by Chonchol, Michel, MD, Locatelli, Francesco, MD, Abboud, Hanna E., MD, Charytan, Chaim, MD, de Francisco, Angel L.M., MD, Jolly, Shivinder, MD, Kaplan, Mark, MD, Roger, Simon D., MD, Sarkar, Shyamal, MD, Albizem, Moetaz B., MD, Mix, T. Christian H., MD, Kubo, Yumi, MS, Block, Geoffrey A., MD

“…Background Secondary hyperparathyroidism is observed in patients with early chronic kidney disease (CKD). This study investigated the safety and efficacy of…”
Get full text

Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study by Vervloet, Marc G, Boletis, Ioannis N, de Francisco, Angel L M, Kalra, Philip A, Ketteler, Markus, Messa, Piergiorgio, Stauss-Grabo, Manuela, Derlet, Anja, Walpen, Sebastian, Perrin, Amandine, Ficociello, Linda H, Rottembourg, Jacques, Wanner, Christoph, Cannata-Andía, Jorge B, Fouque, Denis

“…The iron-based phosphate binder (PB), sucroferric oxyhydroxide (SFOH), is indicated to control serum phosphorus levels in patients with chronic kidney disease…”
Get full text

Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients by de Francisco, Angel L.M., Varas, Javier, Ramos, Rosa, Merello, Jose Ignacio, Canaud, Bernard, Stuard, Stefano, Pascual, Julio, Aljama, Pedro, Aljama, P., Canaud, B., De Francisco, A.L.M., Gauly, A., Luño, J., Maduell, F., Martin-Malo, A., Merello, J.I., Pascual, J., Pérez-Garcia, R., Praga, M., Ramos, R., Stuard, S., Varas, J., Zawada, A.

“…Long-term inappropriate proton pump inhibitors use (PPIs) is a matter of concern because of the risks associated with their long-term use in older patients…”
Get full text

Hemoglobin Variability in Nondialysis Chronic Kidney Disease: Examining the Association with Mortality by Boudville, Neil C, Djurdjev, Ognjenka, Macdougall, Iain C, de Francisco, Angel L M, Deray, Gilbert, Besarab, Anatole, Stevens, Paul E, Walker, Rowan G, Ureña, Pablo, Iñigo, Pablo, Minutolo, Roberto, Haviv, Yosef S, Yeates, Karen, Agüera, Marisa L, MacRae, Jennifer M, Levin, Adeera

“…Anemia and hemoglobin (Hb) variability are associated with mortality in hemodialysis patients who are on erythropoiesis-stimulating agents (ESA). Our aim was…”
Get full text

Onco-Nefrología: cáncer, quimioterapia y riñón by de Francisco, Angel L.M., Macía, Manuel, Alonso, Fabiola, García, Patricia, Gutierrez, Eduardo, Quintana, Luis Fernando, Quiroga, Borja, Torregrosa, Isidro

“…La enfermedad renal crónica (ERC), el cáncer y las enfermedades hematológicas comparten áreas de influencia recíproca. El cáncer puede afectar al riñón bien…”
Get full text

Monographic consultation of onconephrology. Rationale and implementation by Alonso, Fabiola, Auñón, Pilar, Cavero, Teresa, Salgueira, Mercedes, Praga, Manuel, Quiroga, Borja, de Francisco, Ángel L.M., Macía, Manuel

“…The increase in demand for medical care for renal complications associated with neoplastic diseases is a reality in most nephrology departments. In response to…”
Get full text

Adverse renal effects of check-point inhibitors (ICI) in cancer patients: Recommendations of the Onco-nephrology Working Group of the Spanish Society of Nephrology by Alonso, Fabiola, Martín de Francisco, Ángel L M, Auñón, Pilar, García-Carro, Clara, García, Patricia, Gutiérrez, Eduardo, Mcía, Manuel, Quintana, Luis F, Quiroga, Borja, Soler, María José, Torregrosa, Isidro

“…The most widely used approach in the immunotherapy treatment of cancer is the administration of monoclonal antibodies directed against regulatory molecules of…”
Get full text

Oral hydration as a safe prophylactic measure to prevent post-contrast acute kidney injury in oncologic patients with chronic kidney disease (IIIb) referred for contrast-enhanced computed tomography: subanalysis of the oncological group of the NICIR study by Sebastià, Carmen, Páez-Carpio, Alfredo, Guillen, Elena, Paño, Blanca, Arnaiz, Joan Albert, De Francisco, Angel L. M., Nicolau, Carlos, Oleaga, Laura

“…Background T he objective of this study is to evaluate oral hydration compared to intravenous (i.v.) hydration in the prevention of post-contrast acute kidney…”
Get full text

Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability by de Francisco, Angel L.M., Leidig, Michael, Covic, Adrian C., Ketteler, Markus, Benedyk-Lorens, Ewa, Mircescu, Gabriel M., Scholz, Caecilia, Ponce, Pedro, Passlick-Deetjen, Jutta

“…Background. Phosphate binders are required to control serum phosphorus in dialysis patients. A phosphate binder combining calcium and magnesium offers an…”
Get full text

Consulta monográfica de onconefrología. Justificación y puesta en marcha by Alonso, Fabiola, Auñón, Pilar, Cavero, Teresa, Salgueira, Mercedes, Praga, Manuel, Quiroga, Borja, de Francisco, Ángel L.M., Macía, Manuel

“…El incremento de la demanda asistencial por afección renal asociada a enfermedades neoplásicas es una realidad en la mayoría de los servicios de nefrología…”
Get full text

Beyond the cardiorenal anaemia syndrome: recognizing the role of iron deficiency by Macdougall, Iain C., Canaud, Bernard, de Francisco, Angel L.M., Filippatos, Gerasimos, Ponikowski, Piotr, Silverberg, Donald, van Veldhuisen, Dirk J., Anker, Stefan D.

“…Growing awareness that heart failure, renal impairment, and anaemia are frequent co‐morbidities which can exacerbate one another in a vicious circle of…”
Get full text

Post-contrast acute kidney injury in cancer patients by de Francisco, Angel L.M., Guillén, Marta Arias, Pérez-Valderrama, Begoña, Sebastia, Carmen

Get full text

Effect of calcium acetate/magnesium carbonate in the treatment of hyperphosphataemia in dialysis patients in real clinical practice. One year follow up by de Francisco, Angel L M, Belmar, Lara, Piñera, Celestino, Kislikova, María, Seras, Miguel, Serrano, Mara, Albines, Zoila, Sango, Cristina, Arias, Manuel

“…This observational study was conducted to investigate the use and effectiveness of calcium acetate/magnesium carbonate (CaMg) in the treatment of…”
Get more information

Efectos renales adversos por inhibidores del check-point (ICP) en pacientes con cáncer. Recomendaciones del grupo de Onconefrología de la Sociedad Española de Nefrología (SEN) by Alonso, Fabiola, Martín de Francisco, Ángel L.M., Auñón, Pilar, García-Carro, Clara, García, Patricia, Gutiérrez, Eduardo, Macía, Manuel, Quintana, Luis F., Quiroga, Borja, Soler, María José, Torregrosa, Isidro

“…El enfoque más utilizado en el tratamiento inmunoterápico del cáncer es la administración de anticuerpos monoclonales dirigidos contra moléculas reguladoras…”
Get full text

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients by Izquierdo, María Jesús, Cavia, Mónica, Muñiz, Pilar, de Francisco, Angel L M, Arias, Manuel, Santos, Javier, Abaigar, Pedro

“…Treatment with selective vitamin D receptor activators such as paricalcitol have been shown to exert an anti-inflammatory effect in patients on hemodialysis,…”
Get full text